Stay updated on Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2. This appears to be an administrative metadata change rather than any modification to study details or content.
    Difference
    0.1%
    Check dated 2025-12-01T17:38:48.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added and v3.2.0 was removed; this is a minor version-label update that does not alter study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:44:51.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Removed the government funding status notice/banner indicating potential delays and NIH operating status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T07:20:36.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    No additions or deletions are present; the page content remains unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T01:23:18.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    5%
    Check dated 2025-10-05T10:26:37.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:23:42.000Z thumbnail image

Stay in the know with updates to Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.